Longitude (Cayman) Ltd. Amarin Corp Plcuk Call Options Transaction History

Longitude (Cayman) Ltd.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$2.85 - $3.73 $342,000 - $447,600	-120,000 Reduced 66.67%	60,000 $197,000
Q4 2021 Feb 03, 2022	BUY	$3.24 - $5.18 $194,400 - $310,800	60,000 Added 50.0%	180,000 $607,000
Q3 2021 Nov 08, 2021	BUY	$3.94 - $5.84 $137,112 - $203,232	34,800 Added 40.85%	120,000 $612,000
Q2 2021 Aug 10, 2021	SELL	$4.26 - $6.5 $829,848 - $1.27 Million	-194,800 Reduced 69.57%	85,200 $373,000
Q1 2021 May 11, 2021	BUY	$5.03 - $8.8 $12,575 - $22,000	2,500 Added 0.9%	280,000 $1.74 Million
Q4 2020 Feb 11, 2021	BUY	$4.04 - $5.31 $1.12 Million - $1.47 Million	277,500 New	277,500 $1.36 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

Stay updated on Longitude (Cayman) Ltd. with notifications on news.